{"version":"https://jsonfeed.org/version/1","title":"RAHE Life Science","home_page_url":"https://rahelifescience.com","description":"RAHE Life Science","author":{"name":"RAHE Life Science"},"items":[{"id":"https://rahelifescience.com/news-letters/f/india%E2%80%99s-clinical-trial-boom-decoded-cdsco-approval-guideline","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/wAkek6q\"/><p>India is entering a new phase in clinical research. Once viewed primarily as a cost-efficient destination for large, late-stage studies, the country is increasingly positioning itself as a broader hub for clinical develo...</p>","url":"https://rahelifescience.com/news-letters/f/india%E2%80%99s-clinical-trial-boom-decoded-cdsco-approval-guideline","title":"India’s Clinical Trial Boom, Decoded: CDSCO Approval Guideline","summary":"India is entering a new phase in clinical research. Once viewed primarily as a cost-efficient destination for large, late-stage studies, the country is increasingly positioning itself as a broader hub for clinical develo...","date_modified":"2026-08-31T15:33:32Z"}]}